How to Qualify for Semaglutide on Hers: Eligibility & Process

You’ve probably seen the ads. People losing 15% of their body weight in a year without spending hours at the gym or starving themselves. It sounds too good to be true, but for many, it’s real thanks to semaglutide, a medication originally designed for type 2 diabetes that has revolutionized weight management. If you’re looking to get this drug through an online provider like Hers, you might be wondering: do I actually qualify? It’s not just about wanting to lose weight; there are specific medical criteria and safety checks involved.

Hers (and its sister brand Hims) operates as a telehealth platform, meaning you don’t walk into a clinic. You talk to a licensed healthcare provider via video or chat. This convenience is great, but it also means the screening process is strict. They need to ensure the drug is safe for you before writing that prescription. Let’s break down exactly what you need to know to pass that initial screening.

Understanding the Medical Criteria for Prescription

The first hurdle isn’t your desire to lose weight-it’s your Body Mass Index (BMI). In the US and Australia, where these services often operate under similar FDA/TGA guidelines, semaglutide for weight loss (often branded as Wegovy, though compounded versions exist) is typically reserved for adults with obesity or overweight conditions linked to other health issues.

Generally, you need one of the following profiles to be considered eligible:

• BMI of 30 or higher: This is classified as obesity. Regardless of other health conditions, if your BMI hits this mark, you are likely a candidate.
• BMI of 27 or higher with comorbidities: If your BMI is between 27 and 29.9, you usually need at least one weight-related condition. Common examples include high blood pressure (hypertension), high cholesterol, or prediabetes/type 2 diabetes.

Why these numbers? Clinical trials showed that people outside these ranges didn’t see enough benefit to justify the cost and potential side effects. If you’re trying to drop 5 pounds for a wedding, semaglutide might not be the right tool yet. But if you’re dealing with significant excess weight that impacts your daily life, this could be your pathway.

The Role of Telehealth Providers Like Hers

Hers acts as the bridge between you and the prescribing clinician. Unlike a traditional doctor’s visit where you might discuss lifestyle over coffee, Hers uses structured intake forms and quick consultations. The platform relies on telemedicine technology to assess patient history efficiently.

When you sign up, you’ll complete a detailed health questionnaire. This isn’t just busywork. The provider reviewing your case needs to rule out contraindications-conditions where taking semaglutide could be dangerous. For instance, if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), you likely won’t qualify. These rare conditions are serious red flags for GLP-1 receptor agonists.

Another critical factor is pregnancy. Semaglutide is generally not recommended for women who are pregnant, planning to become pregnant, or breastfeeding. The provider will ask direct questions about your reproductive plans because animal studies have shown potential risks to the fetus.

What Happens During the Consultation?

Once you submit your info, a licensed provider reviews your profile. This isn’t always a live video call; sometimes it’s an asynchronous review where they check your data against clinical guidelines. If they have questions, they’ll message you back. Be ready to provide specifics about your current medications. Why? Because semaglutide can interact with certain drugs, particularly those that affect stomach emptying or blood sugar levels.

If you take insulin or sulfonylureas for diabetes, your provider might adjust your dosages. Combining these with semaglutide can cause hypoglycemia (low blood sugar). So, transparency here is non-negotiable. Don’t hide supplements or over-the-counter meds. The provider needs the full picture to keep you safe.

Also, consider your kidney and liver health. While mild impairment might not stop you from getting a prescription, severe kidney disease requires careful monitoring. The provider will look at your recent lab results if you have them. If you haven’t had blood work in years, they might request updated labs before approving the script. This ensures your body can handle the metabolic changes the drug induces.

Cost, Insurance, and Compounded Options

Let’s talk money. Brand-name semaglutide (Wegovy/Ozempic) can cost upwards of $1,000 per month without insurance coverage. Many users find this prohibitive. This is where the distinction between "FDA-approved" and "compounded" matters.

Hers and similar platforms often offer compounded semaglutide when brand-name supplies are short. Compounded versions are made by specialized pharmacies using the same active ingredient but in different formulations (like oral tablets or different injection concentrations). They are often cheaper, ranging from $200 to $400 monthly depending on the dose. However, insurance rarely covers compounded drugs. You’ll likely pay out-of-pocket.

Before signing up, check if your insurance plan covers GLP-1 agonists for weight loss. Some plans require a trial of diet and exercise first. Others demand proof of BMI compliance. If insurance denies it, ask if they cover Ozempic (same drug, different indication) which might have better formulary placement.

Common Reasons for Disqualification

Not everyone gets approved. Here are the most common reasons providers reject applications on platforms like Hers:

• Inconsistent Health Data: If your height and weight don’t match your BMI calculation, or if you report conflicting medical histories, the provider may pause approval until clarified.
• Pregnancy Risk: As mentioned, if you are pregnant or breastfeeding, you are automatically disqualified from starting treatment.
• Gastrointestinal History: A history of severe gastroparesis (paralyzed stomach) can be a disqualifier. Since semaglutide slows digestion, it can worsen this condition significantly.
• Mental Health Concerns: While not an absolute bar, active eating disorders like anorexia nervosa require careful evaluation. Weight loss drugs aren’t typically the first line of defense for these conditions.

If you get rejected, don’t take it personally. It’s a safety protocol. Ask for feedback. Sometimes, providing additional documentation, like a recent doctor’s note confirming your BMI or lab results, can reverse a decision.

Tips to Smooth Your Approval Process

To speed things up, prepare before you start the application. Gather your recent medical records, especially if you have chronic conditions. Know your current medications list. Have a realistic goal in mind. Providers want to see that you understand this isn’t magic-it works best alongside dietary changes.

Be honest about your lifestyle. If you drink alcohol heavily, mention it. If you smoke, disclose it. These factors influence how your body metabolizes drugs and your overall cardiovascular risk. Transparency builds trust with the reviewing clinician and speeds up the green light.

Finally, stay responsive. Telehealth platforms move fast. If the provider asks for clarification, answer quickly. Delays in communication can lead to expired requests or lost spots in the queue, especially during high-demand periods like January or summer pre-seasons.